


Ask a doctor about a prescription for OTILONIO CINFA 40 mg FILM-COATED TABLETS
Patient Information Leaflet
OtiloniumCinfa 40 mg film-coated tablets
otilonium bromide
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the leaflet
Otilonium Cinfa contains the active substance otilonium bromide, which belongs to a group of medicines that act by reducing intestinal contractions.
Otilonium is used to treat spasms and alterations of gastrointestinal motility in adults.
Do not take Otilonium Cinfa
Warnings and precautions
Consult your doctor or pharmacist before starting to take Otilonium Cinfa if:
Children
Do not use this medicine in children and adolescents.
Elderly
Elderly patients should take this medicine with caution.
Other medicines and Otilonium Cinfa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
The safety of otilonium during pregnancy and breastfeeding has not been established.
Driving and using machines
Otilonium does not interfere with the ability to drive vehicles or use machines.
Otilonium Cinfa contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is 1 tablet of otilonium (40 mg of otilonium bromide) two or three times a day, according to medical criteria.
Method of administration:
The tablets are administered orally.
The tablets should be taken approximately 20 minutes before meals with half a glass of water.
The maximum treatment duration is 4 weeks.
In case of reappearance of painful symptoms, the doctor should evaluate the convenience of starting a new treatment.
If you take more Otilonium Cinfa than you should
In case of overdose or accidental ingestion, go immediately to your doctor or pharmacist or call the Toxicology Information Service, phone: 915 62 04 20, indicating the medicine and the amount ingested.
If you forget to take Otilonium Cinfa
Do not take a double dose to make up for forgotten doses.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects of unknown frequency (cannot be estimated from available data):
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiry date stated on the packaging after CAD. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If you have any questions, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Otilonium Cinfa
Appearance and packaging of the product
Otilonium Cinfa is presented in the form of film-coated tablets. The tablets are round and white.
It is presented in PVC/aluminum blisters containing 60 film-coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Manufacturer:
Neuraxpharm Pharmaceuticals S.L.
Avda. Barcelona, 69
08970, Sant Joan Despí (Barcelona)
Spain
or
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Date of last revision of this leaflet:November 2021
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/.
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/79384/P_79384.html.
QR code to: https://cima.aemps.es/cima/dochtml/p/79384/P_79384.html.
The average price of OTILONIO CINFA 40 mg FILM-COATED TABLETS in October, 2025 is around 11.02 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OTILONIO CINFA 40 mg FILM-COATED TABLETS – subject to medical assessment and local rules.